Literature DB >> 8609

Brain tyrosine hydroxylase activity and systolic blood pressure in rats treated with either deoxycorticosterone and salt or angiotensin.

P Rylett, H G Dean, M R Lee.   

Abstract

The hypertension induced in adult male rats by doca/salt was found to be accompanied by a significant rise in whole brain tyrosine hydroxylase (TH) activity. A smaller hypertensive effect, produced by angiotensin (750 ng kg-1 daily) was also accompanied by a proportional rise in whole brain TH activity. The specific antagonists spironolactone and saralasin completely blocked both responses in the doca/salt- and angiotensin-treated animals respectively and spironolactone showed a partial inhibition of the effects of angiotensin. In all the animals treated there was a clear correlation between systolic blood pressure and whole brain TH activity. The significance of these changes is discussed in the light of the central mechanism of hypertension.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 8609     DOI: 10.1111/j.2042-7158.1976.tb02795.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  3 in total

1.  Enhanced assymetrical noradrenergic transmission in the olfactory bulb of deoxycorticosterone acetate-salt hypertensive rats.

Authors:  Tamara Abramoff; María J Guil; Vanina P Morales; Sandra I Hope; Celeste Soria; Liliana G Bianciotti; Marcelo S Vatta
Journal:  Neurochem Res       Date:  2013-07-26       Impact factor: 3.996

Review 2.  Tyrosine hydroxylase regulation in the central nervous system.

Authors:  J M Masserano; N Weiner
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

3.  Chronic Blockade of Brain Endothelin Receptor Type-A (ETA) Reduces Blood Pressure and Prevents Catecholaminergic Overactivity in the Right Olfactory Bulb of DOCA-Salt Hypertensive Rats.

Authors:  Luis R Cassinotti; María J Guil; Mercedes I Schöller; Mónica P Navarro; Liliana G Bianciotti; Marcelo S Vatta
Journal:  Int J Mol Sci       Date:  2018-02-27       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.